While the specific cause of vaping-related illnesses has been widely debated among the general public and physicians, new research points to vitamin E acetate as a potential culprit in the vape-related lung illness outbreak. ![]() There are many available devices to generate this aerosol, including battery-operated electronic cigarettes, e-cigarettes, vape pens, or vape mods. Vaping product use associated lung injury (EVALI, also called vaping associated pulmonary injury ) is an acute or subacute respiratory illness with damage to the alveoli that can be severe and life-threatening. “Vaping” (i.e., heating) is the practice of inhaling an aerosol created by heating a liquid or wax containing substances, such as nicotine, cannabinoids such as tetrahydrocannabinol (THC), cannabidiol, additives, and flavorings such as propylene glycol, glycerol and flavored nicotine. This review article summarizes the growing knowledge of acute respiratory complications associated with vaping. ![]() There is growing evidence that vaping is hazardous to your health including immediate health dangers such as death from respiratory causes, long term health effects, cardiovascular events, depression which increases the risk of suicidal thoughts and suicide. The mysterious outbreak is identified in individuals vaping within the 90 days, ranging over a few days to developing over several weeks. Vitamin E acetate is a condensing agent in vaping products, and all injured lung fluid samples appear to harbor this agent. CDC has detected vitamin E acetate as a chemical of concern among people with the lung injury. Symptoms of difficulty breathing, shortness of breath, chest pains, gastrointestinal sickness leading to serious lung damage and death has been linked to the risk behavior of using vaping products bought on the streets in healthy young people. The United States Federal Centers for Disease Control and Prevention (CDC) has been working with state investigators on reported cases of lung illnesses linked to e-cigarette or vaping products.
0 Comments
Leave a Reply. |